Literature DB >> 7020931

Relationship of steroid receptor, cell kinetics, and clinical status in patients with breast cancer.

T E Kute, H B Muss, D Anderson, K Crumb, B Miller, D Burns, L A Dube.   

Abstract

The fractions of cells in the different phases of the cell cycle were determined by flow cytometry in 70 human breast tumors and six human benign breast tissues. This procedure showed that 44% of the tumors and none of the benign tissues were aneuploid as determined by mixing experiments using normal peripheral blood as a standard for DNA content per nucleus. The mean percent S-phase fraction (% S) values +/- S.D. for benign and malignant tissues were 6.9 +/- 1.6 and 13.7 +/- 6.5, respectively. By our procedure, aneuploid tumors seem to have significantly higher mean % S value than do diploid tumors. Breast cancer tissue which contained steroid receptors had a mean % S value of 11.3, while those tumors which had neither the estrogen nor progesterone receptors had a mean % S value of 17.1 (p less than 0.01). The estrogen receptor status had a better inverse relationship to the cell kinetic data than did the progesterone receptor status. The use of molecular forms of the steroid receptor was of some assistance in improving the inverse relationship between cell kinetics and steroid receptor status. A trend was observed between lack of steroid receptors and higher probability of the tumor being aneuploid. From the limited clinical data, there was no relationship between cell kinetic and aneuploid data with respect to nodal status, metastatic disease, and menopausal status. The possible use of these data is discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7020931

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  29 in total

1.  Significance of Flow Cytometric DNA Analysis from Freshly Aspirated Samples.

Authors: 
Journal:  Breast Cancer       Date:  1995-10-31       Impact factor: 4.239

2.  An Evaluation of DNA Polymerase alpha as a Prognostic Predictor in Early Breast Cancers Smaller than 2 cm.

Authors: 
Journal:  Breast Cancer       Date:  1995-04-30       Impact factor: 4.239

3.  Biological indices in the assessment of breast cancer.

Authors:  A S Leong; A K Lee
Journal:  Clin Mol Pathol       Date:  1995-10

4.  p53 status does not determine outcome of E1B 55-kilodalton mutant adenovirus lytic infection.

Authors:  F D Goodrum; D A Ornelles
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

5.  Lymph node metastases versus DNA ploidy as prognostic factors for invasive ductal carcinoma of the breast.

Authors:  M Noguchi; T Taniya; N Ohta; N Koyasaki; I Miyazaki; Y Mizukami
Journal:  Breast Cancer Res Treat       Date:  1991-09       Impact factor: 4.872

6.  Relationship of flow cytometry results to clinical and steroid receptor status in human breast cancer.

Authors:  T E Kute; H B Muss; M Hopkins; R Marshall; D Case; L Kammire
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

Review 7.  Clinical and biological significance of aneuploidy in human tumours.

Authors:  M L Friedlander; D W Hedley; I W Taylor
Journal:  J Clin Pathol       Date:  1984-09       Impact factor: 3.411

Review 8.  Practical breast carcinoma cell kinetics: review and update.

Authors:  J S Meyer; R W McDivitt; K R Stone; M U Prey; W C Bauer
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

9.  Significance of the Tritiated Thymidine Labeling Index in breast cancers.

Authors:  K Araki; M Kimura; K Sakamoto; R Nishimura; M Akagi
Journal:  Jpn J Surg       Date:  1985-03

10.  DNA ploidy and helix pomatia lectin binding as predictors of regional lymph node metastases and prognostic factors in breast cancer.

Authors:  M Noguchi; M Thomas; H Kitagawa; K Kinishita; S Kinami; H Takamura; I Miyazaki; Y Mizukami
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.